DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
基本信息
- 批准号:7194967
- 负责人:
- 金额:$ 20.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAge-YearsAllelesAutosomal Dominant Polycystic KidneyBiological AssayCationsCell ExtractsCell LineCell divisionCellsCharacteristicsChromatin StructureChromosomes, Human, Pair 16Chronic Kidney FailureConditionDNADNA RepairDNA StructureDNA biosynthesisDNA replication forkDNA-Binding ProteinsDataDeletion MutagenesisDevelopmentDigestionDiseaseEnd stage renal failureEnvironmentEventFLP recombinaseFree EnergyGelGene ConversionGenesGenetic RecombinationGoalsHela CellsHelix (Snails)HumanIn VitroKidneyLeadLifeLocationLoss of HeterozygosityMammalian CellMeasuresMediatingMolecularMonitorMutagenesisMutationOnset of illnessPKD1 genePatientsPatternPhenotypePolymerase Chain ReactionProcessProteinsReactionRecruitment ActivityRenal Replacement TherapyReplication InitiationReplication OriginReporterResearchScoreSeverity of illnessSiteSomatic MutationStructureSystemSystems IntegrationTSC2 geneTestingTherapeuticThermodynamicsTissuesTransfectionTuberous sclerosis protein complexTwo-Dimensional Gel ElectrophoresisYeastsc-myc Genesear helixin vivokidney cellmeltingnucleaserepairedresearch studytwo-dimensionalvector
项目摘要
DESCRIPTION (provided by applicant): Patients with tuberous sclerosis complex and autosomal dominant polycystic kidney disease most often are born with anatomically normal kidneys but develop significant renal involvement as they age. The abnormal tissues in these diseases are associated with the loss of heterozygosity (LOH) such that only the defective allele is present at the disease locus. Although both diseases have a second associated gene, the TSC2 and PKD1 genes cause a more severe phenotype and are more often found in patients with new mutations. We postulate that the disease severity is related to the fact that these adjacent genes are in an unstable region of chromosome 16. We present evidence that inverted Alu repeats and polypurine.polypyrimidine tracts from these genes appear to be associated with deletions, and block the human replication fork. In addition, the polypurine.polypyrimidine tract, under conditions that favor alternative secondary structure formation, can spontaneously initiate replication. Such replication initiation and termination phenomenon have both developmental and mutagenic implications.
The ultimate goal of our reseach is to retard disease onset and progression by delaying the second somatic mutation leading to the LOH in the TSC2 and PKD1 genes. We hypothesize that alternative DNA secondary structures in the TSC2 and PKD1 genes promote mutagenesis through their effects on DNA replication. The proposed studies investigate the DNA structural characteristics of the Pu.Py tracts and inverted Alu repeats using 2-dimensional gel and melting curve analyses. Using repair deficient cell lines, we will also determine the replication proteins involved. Using a stable-transfection system, we will measure the ability of the sequences to stall replication and to induce recombination. The potential to initiate the human replication fork will also be studied in a well characterized system. By understanding the effects of these sequences on the fidelity of DNA replication, therapeutic inroads into delaying disease onset can be made.
描述(由申请人提供):患有结节性硬化症和常染色体显性多囊肾病的患者通常出生时肾脏解剖结构正常,但随着年龄的增长,肾脏会出现明显的受累。这些疾病中的异常组织与杂合性缺失(LOH)相关,因此疾病位点上仅存在缺陷等位基因。尽管这两种疾病都有第二个相关基因,但 TSC2 和 PKD1 基因会导致更严重的表型,并且更常见于有新突变的患者。我们假设疾病的严重程度与这些相邻基因位于 16 号染色体不稳定区域的事实有关。我们提供的证据表明,这些基因的反向 Alu 重复序列和聚嘌呤。聚嘧啶束似乎与缺失相关,并阻止人类复制叉。此外,多聚嘌呤.多聚嘧啶束在有利于替代二级结构形成的条件下可以自发地启动复制。这种复制起始和终止现象具有发育和诱变的意义。
我们研究的最终目标是通过延迟导致 TSC2 和 PKD1 基因 LOH 的第二个体细胞突变来延缓疾病的发生和进展。我们假设 TSC2 和 PKD1 基因中的替代 DNA 二级结构通过影响 DNA 复制来促进诱变。拟议的研究使用二维凝胶和熔解曲线分析研究了 Pu.Py 束和反向 Alu 重复序列的 DNA 结构特征。使用修复缺陷细胞系,我们还将确定涉及的复制蛋白。使用稳定转染系统,我们将测量序列阻止复制和诱导重组的能力。还将在一个充分表征的系统中研究启动人类复制叉的潜力。通过了解这些序列对 DNA 复制保真度的影响,可以在延缓疾病发作方面取得进展。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?
结节性硬化症和 von Hippel-Lindau 病的肾脏受累:共同的疾病机制?
- DOI:10.1038/ncpneph1032
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Siroky,BrianJ;Czyzyk-Krzeska,MariaF;Bissler,JohnJ
- 通讯作者:Bissler,JohnJ
PKD1 intron 21: triplex DNA formation and effect on replication.
PKD1 内含子 21:三链体 DNA 形成及其对复制的影响。
- DOI:10.1093/nar/gkh312
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Patel,HirenP;Lu,Lu;Blaszak,RichardT;Bissler,JohnJ
- 通讯作者:Bissler,JohnJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN J BISSLER其他文献
JOHN J BISSLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN J BISSLER', 18)}}的其他基金
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
RAD001 血管平滑肌脂肪瘤治疗 TSC 患者
- 批准号:
7607778 - 财政年份:2007
- 资助金额:
$ 20.58万 - 项目类别:
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
RAD001 血管平滑肌脂肪瘤治疗 TSC 患者
- 批准号:
7374557 - 财政年份:2005
- 资助金额:
$ 20.58万 - 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
- 批准号:
6740173 - 财政年份:2003
- 资助金额:
$ 20.58万 - 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
- 批准号:
6859415 - 财政年份:2003
- 资助金额:
$ 20.58万 - 项目类别:
Utility of Rapamycin for the Treatment of Renal Angiomy*
雷帕霉素治疗肾血管瘤的效用*
- 批准号:
6795885 - 财政年份:2003
- 资助金额:
$ 20.58万 - 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
- 批准号:
7030211 - 财政年份:2003
- 资助金额:
$ 20.58万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 20.58万 - 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
- 批准号:
10679558 - 财政年份:2023
- 资助金额:
$ 20.58万 - 项目类别:
Social Connectedness and Health among Gender Minority People of Color
性别少数有色人种的社会联系和健康
- 批准号:
10650066 - 财政年份:2023
- 资助金额:
$ 20.58万 - 项目类别:
Vascular Determinants of Anesthesia-Induced Hypotension at the Extremes of Age
极端年龄时麻醉引起的低血压的血管决定因素
- 批准号:
10711597 - 财政年份:2023
- 资助金额:
$ 20.58万 - 项目类别:
Improving sleep and circadian functioning, daytime functioning, and well-being for midlife and older adults by improving patient memory for a transdiagnostic sleep and circadian treatment
通过改善患者对跨诊断睡眠和昼夜节律治疗的记忆,改善中年和老年人的睡眠和昼夜节律功能、日间功能和福祉
- 批准号:
10708424 - 财政年份:2023
- 资助金额:
$ 20.58万 - 项目类别: